How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Mathematical superintelligence startup Harmonic AI Inc. revealed today that NVentures, the venture capital arm of Nvidia Corp., was among the investors in its $120 million Series C round that was ...